BECTON, DICKINSON AND COMPANY Restructuring Reserve, Settled without Cash
BECTON, DICKINSON AND COMPANY (BDX) reported Restructuring Reserve, Settled without Cash of $458.00 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Restructuring and Related Activities
us-gaap:RestructuringReserveSettledWithoutCash2 · last filed 2026-08-06
- BECTON, DICKINSON AND COMPANY restructuring reserve, settled without cash for the quarter ending 2026-06-30 was $16.00M.
- BECTON, DICKINSON AND COMPANY restructuring reserve, settled without cash for the quarter ending 2026-03-31 was $439.00M.
- BECTON, DICKINSON AND COMPANY restructuring reserve, settled without cash for the quarter ending 2025-12-31 was $3.00M.
- BECTON, DICKINSON AND COMPANY restructuring reserve, settled without cash for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
- BECTON, DICKINSON AND COMPANY restructuring reserve, settled without cash for fiscal 2025 was $43.00M, a 58.65% decline from fiscal 2024.
- BECTON, DICKINSON AND COMPANY restructuring reserve, settled without cash for fiscal 2024 was $104.00M, a 246.67% increase from fiscal 2023.
- BECTON, DICKINSON AND COMPANY restructuring reserve, settled without cash for fiscal 2023 was $30.00M, a 20.00% increase from fiscal 2022.
- BECTON, DICKINSON AND COMPANY restructuring reserve, settled without cash for fiscal 2022 was $25.00M, a 525.00% increase from fiscal 2021.
| Period end | Restructuring Reserve, Settled without Cash 3 month | Restructuring Reserve, Settled without Cash 6 month | Restructuring Reserve, Settled without Cash 9 month | Restructuring Reserve, Settled without Cash 12 month |
|---|---|---|---|---|
| 2026-06-30 | $16.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-06 | $455.00M derived: sum of 2 quarters · filed 2026-08-06 | $458.00M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $439.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-07 | $442.00M 10-Q · filed 2026-05-07 | ||
| 2025-12-31 | $3.00M 10-Q · filed 2026-02-09 | |||
| 2025-09-30 | $43.00M 10-K · filed 2025-11-25 | |||
| 2024-09-30 | $104.00M 10-K · filed 2025-11-25 | |||
| 2023-09-30 | $30.00M 10-K · filed 2025-11-25 | |||
| 2022-09-30 | $25.00M 10-K · filed 2024-11-27 | |||
| 2021-09-30 | $4.00M 10-K · filed 2023-11-21 | |||
| 2020-09-30 | $26.00M 10-K · filed 2022-11-22 | |||
| 2017-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-11-22 | $3.00M derived: sum of 2 quarters · filed 2017-11-22 | $5.00M derived: sum of 3 quarters · filed 2017-11-22 | $9.00M 10-K · filed 2017-11-22 |
| 2017-06-30 | $3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-03 | $5.00M derived: sum of 2 quarters · filed 2017-08-03 | $9.00M 10-Q · filed 2017-08-03 | $81.00M derived: sum of 4 quarters · filed 2017-11-22 |
| 2017-03-31 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-02 | $6.00M 10-Q · filed 2017-05-02 | $78.00M derived: sum of 3 quarters · filed 2017-11-22 | |
| 2016-12-31 | $4.00M 10-Q · filed 2017-02-02 | $76.00M derived: sum of 2 quarters · filed 2017-11-22 | ||
| 2016-09-30 | $72.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-11-22 | $39.00M 10-K · filed 2017-11-22 | ||
| 2016-06-30 | -$33.00M 10-Q · filed 2016-08-04 | |||
| 2015-09-30 | $44.00M 10-K · filed 2017-11-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |